Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2022, 7:41 p.m.

/zigman2/quotes/200043077/composite

$

31.45

Change

0.00 0.00%

Volume

Volume 5,211

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 33.25

$ 31.45

Change

-1.80 -5.41%

Day low

Day high

$31.20

$34.10

Open

52 week low

52 week high

$30.25

$79.70

Open

Jay T. Flatley

Founder of Bruker AXS, Inc., Molecular Dynamics, Inc. and Helix OpCo LLC, Jay T. Flatley is an entrepreneur and businessperson who has been at the helm of 9 different companies and presently holds the position of Chairman & Chief Executive Officer for Zymergen, Inc., Chairman for Helix Holdings I, LLC and Chairman of Iridia, Inc. Jay T. Flatley is also Chairman of The Wellcome Trust Ltd. and Chairman at Wellcome Leap, Inc. and on the board of 8 other companies.

In his past career Mr. Flatley held the position of Executive Chairman for Illumina, Inc. and Chairman for GRAIL, Inc. (a subsidiary of Illumina, Inc.), Vice President-Engineering & Strategic Planning at Plexus Computers LLC, Executive Vice President at Manning Technologies, Inc., President, Chief Executive Officer & Director at Molecular Dynamics, Inc., President & Chief Executive Officer at Bruker AXS, Inc. and Executive Vice President-Manning Technologies at Spectra-Physics, Inc.

Jay T. Flatley received a graduate degree and an undergraduate degree from Stanford University and an undergraduate degree from Claremont McKenna College.

Transactions

Date Shares Transaction Value
06/02/2021 2,074   Award at $0 per share. 0
06/01/2021 3,253   Derivative/Non-derivative trans. at $0 per share. 0
12/12/2017 250,000   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Chief Operating Officer & Secretary
Mr. Steve E. Krognes
Treasurer, Chief Financial & Accounting Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Trending Tickers
  • /zigman2/quotes/202561856/composite MSTR-17.84%
  • /zigman2/quotes/205315244/composite DHT-4.09%
X
Powered by StockTwits
Link to MarketWatch's Slice.